Episode 325 - Dr. Viral Shah, Professor of Medicine of Endocrinology Indiana University

In this episode of the Diabetes Innovators Series, Rob interviews Dr. Viral N Shah discussing the Adjust T1D trial, which investigates the effects of semaglutide, a GLP-1 agonist, on adults with type 1 diabetes. The trial aims to explore adjunctive treatment options beyond insulin, focusing on improving glycemic control, weight loss, and overall patient outcomes. Dr. Shah shares insights on the trial's design, results, safety profile, and implications for future diabetes management, emphasizing the need for continued research and community support. Chapters 00:00 Introduction to the Adjust T1D Trial 03:06 Understanding Type 1 Diabetes and Treatment Options 05:46 Results of the Adjust T1D Trial 08:54 Safety and Efficacy of Semaglutide 11:45 Implications for Type 1 Diabetes Management 14:52 Future Research and Community Impact Resources: Dr. Viral Shah

There are no comments yet.

Please log in to write the first comment.